SymbolNATR
NameNATURES SUNSHINE PRODUCTS INC
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address2901 WEST BLUEGRASS BLVD., LEHI, UT 84048
Telephone(801) 341-7900
Fax
Email
Websitehttps://www.natr.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000275053
Description

Natures Sunshine Products Inc is a natural health and wellness company, primarily engaged in the manufacturing and selling of nutritional and personal care products. The company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, and in various other countries. The company operates in four segments namely, Asia, Europe, North America, and Others. It offers products related to general health, immunity, cardiovascular, digestive, personal care and weight management.

Additional info from NASDAQ:
Natures Sunshine Products Inc is a natural health and wellness company, primarily engaged in the manufacturing and selling of nutritional and personal care products. The company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, and in various other countries. The company operates in four segments namely, Asia, Europe, North America, and Others. It offers products related to general health, immunity, cardiovascular, digestive, personal care and weight management.

2026-08-19 20:42

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 🟢 acquired 20.0K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $14.69 Transaction Date: Aug 17, 2026 | Filing ID: 000011

Read more
2026-08-10 23:15

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 🟢 acquired 141.4K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $16.75 ($2.3M) Transaction Date: Aug 06, 2026 | Filing ID: 000010

Read more
2026-08-10 18:34

New Form SCHEDULE 13G/A - NATURES SUNSHINE PRODUCTS INC <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001166152-26-000008 <b>Size:</b> 15 KB

Read more
2026-08-03 17:45

Nature’s Sunshine Appoints Janine Weber as Executive Vice President and President, North America

Read more
2026-07-23 20:05

Nature’s Sunshine Sets Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 5:00 p.m. ET

Read more
2026-06-29 15:59

Herbert Kevin R. 🔴 sold 2.0K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $21.02 Transaction Date: Jun 26, 2026 | Filing ID: 045913

Read more
2026-06-15 22:04

Herbert Kevin R. 🔴 sold 2.0K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $20.75 Transaction Date: Jun 12, 2026 | Filing ID: 043338

Read more
2026-06-11 23:28

Yates Bryant J 🔴 sold 12.0K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $19.90 Transaction Date: Jun 05, 2026 | Filing ID: 042619

Read more
2026-06-03 22:44

Norman Daniel C 🔴 sold 9.7K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $20.64 Transaction Date: Jun 01, 2026 | Filing ID: 040551

Read more
2026-05-22 15:59

Brower Nathan G 🔴 sold 12.0K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $21.84 Transaction Date: May 21, 2026 | Filing ID: 037603

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07447843 Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance… Na Obesity & Overweight Not_Yet_Recruiting 2026-04-01 2026-10-01 ClinicalTrials.gov
NCT06486077 Metabolic Health 1: Power Line Evaluation; Effect Size Determination Na Metabolic Health Completed 2025-05-20 2025-11-28 ClinicalTrials.gov
NCT03685552 Safety Evaluation of a Diet and Nutritional Supplementation Program- Purify 2.0 Na Gastrointestinal Symptoms Completed 2017-08-03 2017-09-13 ClinicalTrials.gov
NCT03098056 Safety and Tolerance of a Nutritional Intervention Program- In.Form 1.2 Na Obesity Completed 2016-08-01 2016-12-31 ClinicalTrials.gov
NCT03097965 Safety Evaluation of a Lifestyle Modification Program In.Form 1.1 Na Obesity Completed 2015-08-01 2015-12-31 ClinicalTrials.gov
Total clinical trials: 5
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
DIET Other Approved Obesity COMPLETED NCT03097965
PROGRAM Other Approved Obesity COMPLETED NCT03097965
PROG2 Other Approved Obesity COMPLETED NCT03098056
Prog: Purify-2 Other Approved Gastrointestinal Symptoms COMPLETED NCT03685552
Power Line Program Other Approved Metabolic Health COMPLETED NCT06486077
Placebo Other Approved Obesity & Overweight NOT_YET_RECRUITING NCT07447843
Redefine Other Approved Obesity & Overweight NOT_YET_RECRUITING NCT07447843
Total products: 7